US4053626A
(en)
*
|
1973-03-13 |
1977-10-11 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Cholesterol level-lowering phenoxyacetic acids
|
AU683838B2
(en)
|
1992-05-19 |
1997-11-27 |
Novogen Research Pty Ltd |
Health supplements containing phyto-oestrogens, analogues or metabolites thereof
|
US5446061A
(en)
*
|
1993-11-05 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
US5407955A
(en)
*
|
1994-02-18 |
1995-04-18 |
Eli Lilly And Company |
Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
|
US5446071A
(en)
*
|
1994-11-18 |
1995-08-29 |
Eli Lilly And Company |
Methods for lowering serum cholesterol
|
CZ212397A3
(en)
*
|
1995-01-13 |
1997-11-12 |
Novo Nordisk As |
Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation
|
BE1010487A6
(nl)
|
1996-06-11 |
1998-10-06 |
Unilin Beheer Bv |
Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
|
AUPO203996A0
(en)
*
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US6043269A
(en)
*
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
CA2270113A1
(en)
*
|
1996-10-28 |
1998-05-07 |
Poul Jacobsen |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
AU4699897A
(en)
*
|
1996-10-28 |
1998-05-22 |
Novo Nordisk A/S |
Novel (-)-enantiomers of (cis)-3,4-chroman derivatives useful in the preve ntion or treatment of estrogen related diseases or syndromes
|
US5958967A
(en)
*
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
AU744403B2
(en)
*
|
1996-10-28 |
2002-02-21 |
Novo Nordisk A/S |
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
US5985306A
(en)
*
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
JP2002503213A
(ja)
*
|
1996-10-28 |
2002-01-29 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患または症候群の防止または治療に有用な新規なcis―3,4―クロマン誘導体
|
JP2001502709A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患または症候群の予防または治療に有用な新規なシス―3,4―クロマン誘導体
|
US5994390A
(en)
*
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
IL129618A0
(en)
*
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
JP2001502711A
(ja)
*
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患又は症候群の予防又は治療において有用な新規のシス―3、4―クロマン誘導体
|
US5919817A
(en)
*
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
ZA979644B
(en)
*
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
ES2188908T3
(es)
*
|
1996-10-28 |
2003-07-01 |
Novo Nordisk As |
Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
|
US6146668A
(en)
|
1997-04-28 |
2000-11-14 |
Novogen, Inc. |
Preparation of isoflavones from legumes
|
WO1998050026A1
(en)
*
|
1997-05-01 |
1998-11-12 |
Novogen Inc |
Treatment or prevention of menopausal symptoms and osteoporosis
|
AUPP112497A0
(en)
*
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
AUPP260798A0
(en)
|
1998-03-26 |
1998-04-23 |
Novogen Research Pty Ltd |
Treatment of medical related conditions with isoflavone containing extracts of clover
|
KR20000001793A
(ko)
*
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
AUPP868599A0
(en)
*
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
US20090233999A1
(en)
*
|
1999-09-06 |
2009-09-17 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ266199A0
(en)
*
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
AUPQ520300A0
(en)
*
|
2000-01-21 |
2000-02-17 |
Novogen Research Pty Ltd |
Food product and process
|
WO2001064665A1
(en)
|
2000-03-01 |
2001-09-07 |
Akzo Nobel N.V. |
Chroman derivatives as estrogenic compounds
|
AUPR363301A0
(en)
*
|
2001-03-08 |
2001-04-05 |
Novogen Research Pty Ltd |
Dimeric isoflavones
|
US20050119301A1
(en)
*
|
2001-03-16 |
2005-06-02 |
Alan Husband |
Treatment of restenosis
|
JP2007511542A
(ja)
*
|
2003-11-18 |
2007-05-10 |
ノボゲン リサーチ ピーティーワイ リミテッド |
イソフラボノイドプロドラッグ、その組成物、それらを使用する治療法
|
AU2004290613B2
(en)
*
|
2003-11-18 |
2010-03-25 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
EP2407462B1
(en)
*
|
2004-09-21 |
2014-07-30 |
Marshall Edwards, Inc. |
Substituted chroman derivatives, medicaments and use in therapy
|
US8080675B2
(en)
*
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
ES2773753T3
(es)
|
2010-11-01 |
2020-07-14 |
Mei Pharma Inc |
Compuestos isoflavonoides y métodos para el tratamiento del cáncer
|
HUE054998T2
(hu)
|
2015-02-02 |
2021-10-28 |
Mei Pharma Inc |
Kombinációs terápiák emlõrák kezelésében való alkalmazásra
|